Anti-3-hydroxy-3-methylglutaryl-CoA Reductase (HMGCR) Immune-Mediated Necrotizing Myopathy
1 clinical trials · Condition
◉ Watch Anti-3-hydroxy-3-methylglutaryl-CoA Reductase (HMGCR) Immune-Mediated Necrotizing Myopathy
| Record | Firm | Date |
|---|---|---|
| The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Mediated Necrotizing Myopathy (NCT06599697) | University of Alabama at Birmingham | 2025-10-27 |
Track Anti-3-hydroxy-3-methylglutaryl-CoA Reductase (HMGCR) Immune-Mediated Necrotizing Myopathy automatically
Every clearance here is in the API, with alerts when new ones post.